(FM) Hematología
Departamento académico
University Medical Center Freiburg
Friburgo de Brisgovia, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Freiburg (8)
2024
-
Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
Blood, Vol. 144, Núm. 8, pp. 873-887
2023
-
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries
Frontiers in Medicine, Vol. 10
-
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
The Lancet Oncology, Vol. 24, Núm. 6, pp. e255-e269
2022
-
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
European Journal of Haematology, Vol. 108, Núm. 1, pp. 73-83
2021
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Blood Cancer Journal, Vol. 11, Núm. 12
2020
2018
-
Diagnosis, treatment, and response assessment in solitary plasmacytoma: Updated recommendations from a European Expert Panel
Journal of Hematology and Oncology, Vol. 11, Núm. 1
2017
-
Is immunotherapy here to stay in multiple myeloma?
Haematologica, Vol. 102, Núm. 3, pp. 423-432